Copenhagen University Hospital at Herlev
herlevhospital.dkLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
76
Active
9
Phase 3
7
Total enrollment
99,356
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Metformin Hydrochloride | — | — | — | — | — | 1 |
Next readouts
- 2026-08-30
Top conditions
- Atherosclerosis5
- Intermittent Claudication5
- Urinary Incontinence4
- Malnutrition3
- Prostatic Neoplasms3
- Breast Cancer3
- Interstitial Cystitis2
- Type 1 Diabetes2
Frequently asked questions about Copenhagen University Hospital at Herlev
- How many clinical trials does Copenhagen University Hospital at Herlev have on ClinicalTrials.gov?
- Copenhagen University Hospital at Herlev is listed as the lead sponsor on 76 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Copenhagen University Hospital at Herlev's trials are in Phase 3?
- 7 of Copenhagen University Hospital at Herlev's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Copenhagen University Hospital at Herlev focus on?
- Copenhagen University Hospital at Herlev's most-studied conditions on ClinicalTrials.gov are Atherosclerosis, Intermittent Claudication, Urinary Incontinence, Malnutrition, Prostatic Neoplasms.
- When are Copenhagen University Hospital at Herlev's next clinical trial readouts?
- Copenhagen University Hospital at Herlev has 1 upcoming primary-completion readout tracked here; the soonest is “Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty”, expected around 2026-08-30.